If you could vote on Brexit now which option would you choose?
   

Moscow takes part in 3rd phase of COVID vaccine trials


The global number of COVID-19 patients passed 30 million this week, and the virus is expected to pick up momentum with the arrival of the fall season as scientists, including Russia's, are striving to develop an effective vaccine against the disease. On Aug. 11, Russia issued a temporary conditional registration to a coronavirus vaccine developed by the Gamaleya Research Institute of Epidemiology and Microbiology. This kind of registration is issued for medicines which are vital to protect the public health in an emergency such as the coronavirus pandemic. The Russian coronavirus vaccine, named as Gam-COVID-Vac (Gamaleya COVID Vaccine) by the developers and with the trade name Sputnik V (V for the vaccine), has a valid registration until Jan. 1, 2021 and suggests holding a third phase of trials involving up to 40,000 people as well as post-clinical research.

Anadolu Agency - September 19, 2020

View the full story here: https://www.aa.com.tr/en/latest-on-coronavirus-outbreak/moscow-takes-part-in-3rd-phase-of-covid-vaccine-trials/1977640